Phio Pharmaceuticals Names New VP and CFO

Phio Pharmaceuticals (PHIO) just unveiled an announcement.

Phio Pharmaceuticals Corp. has appointed Robert M. Infarinato as its new Vice President and Chief Financial Officer, effective August 1, 2024. Bringing over 40 years of experience, including expertise in the pharmaceutical and biotech sectors, Infarinato will receive a base salary of $180,000 and be eligible for performance-based bonuses. His role is on an at-will basis, and he will also participate in the company’s long-term incentive plans. This leadership change coincides with the departure of the former principal accounting officer, Caitlin Kontulis, who will transition to a part-time advisory role.

For an in-depth examination of PHIO stock, go to TipRanks’ Stock Analysis page.